AIF1L and myalgic encephalomeyelitis/chronic fatigue syndrome: Al-though lower levels of AIF1L have been linked to poor prognosis during breast cancer, AIF1L overexpression in a cell line, similar to what is observed for our ME/CFS cohort (Table 2 and Figure 1), suppressed cell spreading and altered cell shape [25].